1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Peripheral T-Cell Lymphoma (PTCL): new trials by email Literature Review of Peripheral T-Cell Lymphoma (PTCL) trials Research Report on Peripheral T-Cell Lymphoma (PTCL)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) HBI-8000 - Peripheral T-Cell Lymphoma (PTCL) | Phase 2 | Completed | HUYABIO International, LLC. | 55 | 2016-11-01 | 2024-09-19 |
Lymphoma, T-Cell, Peripheral (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
HBI-8000 (1)
HUYABIO International, LLC. (1)
Japan (1) · South Korea (1)
Gloria Lee, MD (1)